跳至主要内容
临床试验/CTRI/2024/05/066800
CTRI/2024/05/066800尚未招募2/3 期

A Single Arm Clinical Study To Evaluate The Efficacy Of Duralabhadi Churna In The Management Of Vatik Kasa In Children.

Dr Rukhsana Sheikh1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2024年5月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
45
试验地点
1
主要终点
Improvement in swarabheda & kasa vega after taking

研究概览

简要总结

This is a single arm clinical study in which the medicine Duralabhadi Churnawill be given to 45 patients who have sign and symptoms of Vatik Kasa. The age group taken the study trial will be between 1 and 12 years old. Duralabhadi Churna with Madhu will be given for 5 days or three a day. Dose will be calculated by age formula. Follow-up will be done on the 3rd and 5th days of the case study, for a total duration of 5 days. The final conclusion will be drawn using statistical methods.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
1.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • The patients having minimum 2 symptoms of Vatik Kasa are as follows- 1.The frequency of Kasa vega (Dry Cough) 2.Udarparshwa Shula (chest pain) 3.Swarbheda (Hoarseness of Voice) 4.Shukpurna Galasyata (Feeling Of Thorn Pricking in the Throat) 2) Patients between the ages of 1 year and 12 year.
  • The patients whose parents are ready to participate in the clinical trial by giving informed written consent.

排除标准

  • Patients of other types of kasa (pittaj, kaphaj, kshayaj, kshataj) 2)Patients having life threatening illness and who is bed ridden.
  • Patients having any congenital respiratory and GIT abnormality.
  • Patients who require surgical management.
  • Patients having concomitant other systemic disorders like T.B., Bronchiolitis, Asthma, Pneumonia, Bronchiectasis, Lung abscess, Foreign body, pertussis etc.
  • Patient having complaint of fever or recent history of fever .

结局指标

主要结局

Improvement in swarabheda & kasa vega after taking

时间窗: 5 Days study with followup on 3rd and 5th day

Duralabhadi Churna in the management of Vatik Kasa.

时间窗: 5 Days study with followup on 3rd and 5th day

次要结局

  • To study the Adverse effect of Duralabhadi Churna, if any(5 Days study with followup on 3rd and 5th day (0,3,5 Days))

研究者

发起方
Dr Rukhsana Sheikh
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Rukhsana Sheikh

Dr.D.Y.Patil College Of Ayurveda and Research Centre Pimpri Pune

研究点 (1)

Loading locations...

相似试验

To study the effect of Duralabhadi Churna in vatik... | 临床试验